pSvida to list on Nasdaq

By Dylan Bushell-Embling
Tuesday, 10 June, 2008

WA-based biotech pSvida (ASX: PSD) is to reincorporate onto the Nasdaq, the American stock exchange.

The re-incorporation plan was first mooted in April. At a shareholders' meeting today, 94 per cent of shareholders, 192 in total, voted for the resolution, while six voted against it.

Between them the 192 shareholders hold around 96 per cent of the voting power.

The shareholders also voted to adopt a new employee incentive plan.

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd